Visfatin acts as an oncogenic factor by promoting proliferation, metastasis, angiogenesis, and drug resistance [49] in various solid tumors, including breast [50, 51], colorectal [52], and ovarian cancer [53]. This evidence concerns the gene NAMPT and ovarian carcinoma.